These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22913878)

  • 1. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5.
    Barroso R; Martínez Muñoz L; Barrondo S; Vega B; Holgado BL; Lucas P; Baíllo A; Sallés J; Rodríguez-Frade JM; Mellado M
    FASEB J; 2012 Dec; 26(12):4841-54. PubMed ID: 22913878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBI2 operates independently of but in cooperation with CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center.
    Gatto D; Wood K; Brink R
    J Immunol; 2011 Nov; 187(9):4621-8. PubMed ID: 21948984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spin90 deficiency increases CXCL13-mediated B cell migration.
    Park SH; Kim HR; Jun CD; Song WK; Park SG
    Scand J Immunol; 2014 Sep; 80(3):191-7. PubMed ID: 24965518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics.
    Sáez de Guinoa J; Barrio L; Mellado M; Carrasco YR
    Blood; 2011 Aug; 118(6):1560-9. PubMed ID: 21659539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses.
    Gatto D; Paus D; Basten A; Mackay CR; Brink R
    Immunity; 2009 Aug; 31(2):259-69. PubMed ID: 19615922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
    Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
    Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses.
    Chevalier N; Jarrossay D; Ho E; Avery DT; Ma CS; Yu D; Sallusto F; Tangye SG; Mackay CR
    J Immunol; 2011 May; 186(10):5556-68. PubMed ID: 21471443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.
    Del Grosso F; Coco S; Scaruffi P; Stigliani S; Valdora F; Benelli R; Salvi S; Boccardo S; Truini M; Croce M; Ferrini S; Longo L; Tonini GP
    Mol Cancer Res; 2011 Jul; 9(7):815-23. PubMed ID: 21642390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.
    Cagigi A; Mowafi F; Phuong Dang LV; Tenner-Racz K; Atlas A; Grutzmeier S; Racz P; Chiodi F; Nilsson A
    Blood; 2008 Dec; 112(12):4401-10. PubMed ID: 18780835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBI2 mediates B cell segregation between the outer and centre follicle.
    Pereira JP; Kelly LM; Xu Y; Cyster JG
    Nature; 2009 Aug; 460(7259):1122-6. PubMed ID: 19597478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
    Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
    J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS.
    Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Ransohoff RM; Ness JM; Colliver JA
    J Neuroimmunol; 2012 Feb; 243(1-2):81-8. PubMed ID: 22264765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell localization: regulation by EBI2 and its oxysterol ligand.
    Gatto D; Brink R
    Trends Immunol; 2013 Jul; 34(7):336-41. PubMed ID: 23481574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBI2 regulates intracellular signaling and migration in human astrocyte.
    Rutkowska A; Preuss I; Gessier F; Sailer AW; Dev KK
    Glia; 2015 Feb; 63(2):341-51. PubMed ID: 25297897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5.
    Jiang BC; Cao DL; Zhang X; Zhang ZJ; He LN; Li CH; Zhang WW; Wu XB; Berta T; Ji RR; Gao YJ
    J Clin Invest; 2016 Feb; 126(2):745-61. PubMed ID: 26752644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia.
    Shiao YM; Lee CC; Hsu YH; Huang SF; Lin CY; Li LH; Fann CS; Tsai CY; Tsai SF; Chiu HC
    J Neuroimmunol; 2010 Apr; 221(1-2):101-6. PubMed ID: 20223524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13.
    Halvorsen B; Smedbakken LM; Michelsen AE; Skjelland M; Bjerkeli V; Sagen EL; Taskén K; Bendz B; Gullestad L; Holm S; Biessen EA; Aukrust P
    Atherosclerosis; 2014 Jun; 234(2):352-9. PubMed ID: 24732574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
    Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
    J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia.
    Qiuping Z; Jie X; Youxin J; Qun W; Wei J; Chun L; Jin W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Qun L; Kejian Z; Zhimin S; Junyan L; Jinquan T
    Oncogene; 2005 Jan; 24(4):573-84. PubMed ID: 15580304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.
    Hu C; Xiong J; Zhang L; Huang B; Zhang Q; Li Q; Yang M; Wu Y; Wu Q; Shen Q; Gao Q; Zhang K; Sun Z; Liu J; Jin Y; Tan J
    Cell Mol Immunol; 2004 Aug; 1(4):280-94. PubMed ID: 16225771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.